Skip to main content

Table 4 Acceptance rate of healthcare professionals in absolute numbers and %

From: Evaluation and validation of a clinical decision support system for dose optimisation in hospitalized patients with (morbid) obesity – a retrospective, observational study

 

Alerts

Actions (alerts accepted) by pharmacist, n (%)

Actions (alerts accepted) by physician, n (%)

Administration to the patient (alerts fully accepted), n (%)

Dabigatran

9

7 (77.8)

4 (44.4)

4 (44.4)

Edoxaban

1

1 (100.0)

1 (100.0)

1 (100.0)

Ciprofloxacin

65

43 (66.2)

29 (44.6)

24 (36.9)

Vancomycin

58

16 (27.6)

9 (15.5)

4 (6.9)

Dalteparin – collectively

1086

502 (46.2)

386 (35.5)

309 (28.5)

Dalteparin – anti-Xa level

116

51 (44.0)

33 (28.5)

19 (16.4)

Dalteparin – therapeutic

154

56 (35.9)

29 (18.6)

23 (15.6)

Dalteparin – prophylactic

816

395 (48.4)

324 (39.7)

267 (32.7)